IPO registrations (S-1, F-1) · Registrants
Intercure Ltd.
- SEC CIK
- 1857030 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2021-07-15, last 2021-09-23; 1 initial registration, 3 amendments
- Outcome
- Declared effective 2021-10-04
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- L3
- Business address
- 85 MEDINAT HA-YEHUDIM STREET, Herzliya, L3 4676670
- Ticker
- INCR (Nasdaq)
- EDGAR entity type
- other
- Insiders and CEO pay
- Intercure Ltd. on the corporate pages
Offering terms
- Shares offered
- 5,937,726
- Listing
- Nasdaq under the symbol INCR
- Lead underwriters
- of Contents
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: Intercure Ltd. EXACT (CIK (EXACT))
- SEC filer: Intercure Ltd. EXACT (CIK (EXACT))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-07-15 | F-1 | F-1 (foreign registration) | Intercure Ltd. | 0001493152-21-016926 ↗ |
| 2021-08-03 | F-1/A | F-1/A (amendment) | Intercure Ltd. | 0001493152-21-018348 ↗ |
| 2021-09-09 | F-1/A | F-1/A (amendment) | Intercure Ltd. | 0001493152-21-022277 ↗ |
| 2021-09-23 | F-1/A | F-1/A (amendment) | Intercure Ltd. | 0001493152-21-023477 ↗ |
| 2021-10-04 | EFFECT | EFFECT (declared effective) | Intercure Ltd. | 9999999995-21-003761 ↗ |
| 2022-06-24 | EFFECT | EFFECT (declared effective) | Intercure Ltd. | 9999999995-22-001873 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-23 | F-1/A | registration statement | 5,937,726 | - | Nasdaq INCR | 1 | primary document; shares headline, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Cohen Amos | Officer | Chief Financial Officer | 2 | 2026 | |
| Hirschfeld Gideon | Director | 1 | 2026 | ||
| Salton David | Director | 1 | 2026 | ||
| Granot Alon Shmuel | Director | 1 | 2026 | ||
| Michelson Lennie Grinbaum | Director | 1 | 2026 | ||
| Rabinovich Alexander | Director,Officer | Chief Executive Officer | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-08-19 | Intercure Ltd. | Pharmaceuticals | Indefinite | $0 | 15 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | Intercure Ltd. | Form D private offerings | CIK (EXACT) | |
| SEC filer | Intercure Ltd. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, L3 first:
- CANNAPOWDER, INC. L3
- Rosetta Genomics Ltd. L3
- BIOCANCELL THERAPEUTICS INC. L3
- Can-Fite BioPharma Ltd. L3
- RedHill Biopharma Ltd. L3
- KAMADA LTD L3
- MAPI - PHARMA LTD L3
- NeuroDerm Ltd. L3
- Advanced Inhalation Therapies (AIT) Ltd. L3
- Silenseed Ltd. L3
In other datasets, the same topic (Health) in L3:
- Form D issuer: Agada Medical Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health